Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials.
Nanda
Akash
A
Harvard Radiation Oncology Program, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA. ananda@partners.org
D'Amico
Anthony V
AV
D000728:Androgens / Q000378:metabolism; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000628:therapy*; D011829:Radiation Dosage; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D000728:Androgens; D018931:Antineoplastic Agents, Hormonal